Literature DB >> 12522073

Shaker-type Kv1 channel blockers increase the peristaltic activity of guinea-pig ileum by stimulating acetylcholine and tachykinins release by the enteric nervous system.

Rosane Vianna-Jorge1, Cyntia F Oliveira, Maria L Garcia, Gregory J Kaczorowski, Guilherme Suarez-Kurtz.   

Abstract

1 A constant intraluminal pressure system was used to evaluate the effects of Kv1 channel blockers on the peristaltic activity of guinea-pig ileum. 2 The nortriterpene correolide, a non-selective inhibitor of all Kv1 sub-types, causes progressive and sustained reduction of the pressure threshold for eliciting peristaltic contractions. 3 Margatoxin (MgTX), alpha-dendrotoxin (alpha-DTX) and dendrotoxin-K (DTX-K), highly selective peptidyl inhibitors of certain Kv1 sub-types, cause immediate reduction of the pressure threshold. This effect subsides with time, irrespective of the peptides' concentration in the bath. In preparations pretreated with saturating concentrations of MgTX, correolide further stimulates the peristaltic activity. 4 Iberiotoxin (IbTX), a selective inhibitor of the high-conductance Ca(2+)-activated K(+) (BK) channels, and charybdotoxin (ChTX), which inhibits Kv1.2 and Kv1.3 as well as BK channels, fail to stimulate the peristaltic activity. 5 Blockade of muscarinic receptors by atropine reduces, and occasionally suppresses the peristaltic activity of guinea-pig ileum. In atropine-treated preparations, correolide and MgTX retain their abilities to reduce the pressure threshold and are able to restore the peristaltic reflex in the preparations where this reflex was suppressed by atropine. 6 The stimulatory effect of correolide and MgTX in atropine-treated preparations is abolished by subsequent addition of selective antagonists of both NK1 and NK2 receptors. 7 In conclusion, blockade of Kv1, particularly Kv1.1 channels, increases the peristaltic activity of guinea-pig ileum by enhancing the release of neurotransmitters at the enteric nervous system. In contrast, stimulation of the myogenic motility by blockade of BK channels does not affect the threshold for the peristaltic reflex.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522073      PMCID: PMC1573649          DOI: 10.1038/sj.bjp.0705023

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Binding of correolide to K(v)1 family potassium channels. Mapping the domains of high affinity interaction.

Authors:  M Hanner; W A Schmalhofer; B Green; C Bordallo; J Liu; R S Slaughter; G J Kaczorowski; M L Garcia
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

2.  Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.

Authors:  J P Felix; R M Bugianesi; W A Schmalhofer; R Borris; M A Goetz; O D Hensens; J M Bao; F Kayser; W H Parsons; K Rupprecht; M L Garcia; G J Kaczorowski; R S Slaughter
Journal:  Biochemistry       Date:  1999-04-20       Impact factor: 3.162

3.  Peptidyl inhibitors of shaker-type Kv1 channels elicit twitches in guinea pig ileum by blocking kv1.1 at enteric nervous system and enhancing acetylcholine release.

Authors:  G Suarez-Kurtz; R Vianna-Jorge; B F Pereira; M L Garcia; G J Kaczorowski
Journal:  J Pharmacol Exp Ther       Date:  1999-06       Impact factor: 4.030

4.  Characterization of the cloned human intermediate-conductance Ca2+-activated K+ channel.

Authors:  B S Jensen; D Strobaek; P Christophersen; T D Jorgensen; C Hansen; A Silahtaroglu; S P Olesen; P K Ahring
Journal:  Am J Physiol       Date:  1998-09

5.  Binding of correolide to the K(v)1.3 potassium channel: characterization of the binding domain by site-directed mutagenesis.

Authors:  M Hanner; B Green; Y D Gao; W A Schmalhofer; M Matyskiela; D J Durand; J P Felix; A R Linde; C Bordallo; G J Kaczorowski; M Kohler; M L Garcia
Journal:  Biochemistry       Date:  2001-10-02       Impact factor: 3.162

6.  The inhibitory modulation of guinea-pig intestinal peristalsis caused by capsaicin involves calcitonin gene-related peptide and nitric oxide.

Authors:  L Bartho; P Holzer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

7.  Functional and molecular expression of a voltage-dependent K(+) channel (Kv1.1) in interstitial cells of Cajal.

Authors:  W J Hatton; H S Mason; A Carl; P Doherty; M J Latten; J L Kenyon; K M Sanders; B Horowitz
Journal:  J Physiol       Date:  2001-06-01       Impact factor: 5.182

8.  Correolide, a nor-triterpenoid blocker of Shaker-type Kv1 channels elicits twitches in guinea-pig ileum by stimulating the enteric nervous system and enhancing neurotransmitter release.

Authors:  R Vianna-Jorge; C F Oliveira; M L Garcia; G J Kaczorowski; G Suarez-Kurtz
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

9.  Effects of the K+ channel blockers paspalitrem-C and paxilline on mammalian smooth muscle.

Authors:  F P DeFarias; M F Carvalho; S H Lee; G J Kaczorowski; G Suarez-Kurtz
Journal:  Eur J Pharmacol       Date:  1996-10-24       Impact factor: 4.432

10.  Ca2+-entry blockade by CAF603, a carotane sesquiterpene isolated from Trichoderma virens.

Authors:  G Suarez-Kurtz; J H Nascimento; J G Ondeyka; G J Kaczorowski
Journal:  Eur J Pharmacol       Date:  1997-09-24       Impact factor: 4.432

View more
  3 in total

1.  A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library.

Authors:  Zoltan Takacs; Megan Toups; Astrid Kollewe; Erik Johnson; Luis G Cuello; Gregory Driessens; Matthew Biancalana; Akiko Koide; Cristiano G Ponte; Eduardo Perozo; Thomas F Gajewski; Guilherme Suarez-Kurtz; Shohei Koide; Steve A N Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

Review 2.  K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.

Authors:  Heike Wulff; Boris S Zhorov
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

3.  Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers: WO2010066840.

Authors:  Heike Wulff
Journal:  Expert Opin Ther Pat       Date:  2010-10-18       Impact factor: 6.674

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.